$INUV
Inuvo, Inc.

2024 Q3 Form 10-Q Financial Statement

#000165495424010179 Filed on August 08, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2 2023 Q2
Revenue $22.37M $18.21M $16.65M
YoY Change -8.95% 9.35% -26.49%
Cost Of Revenue $2.595M $2.906M $2.369M
YoY Change 14.07% 22.7% -74.46%
Gross Profit $19.78M $15.30M $14.28M
YoY Change -11.3% 7.14% 6.77%
Gross Profit Margin 88.4% 84.04% 85.78%
Selling, General & Admin $17.00M $14.37M
YoY Change 18.33% -11.39%
% of Gross Profit 111.11% 100.6%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $440.9K $430.7K $705.6K
YoY Change 4.77% -38.96% 89.19%
% of Gross Profit 2.23% 2.81% 4.94%
Operating Expenses $21.72M $17.00M $17.62M
YoY Change -7.52% -3.52% 8.67%
Operating Profit -$1.943M -$1.699M -$3.339M
YoY Change 63.15% -49.11% 17.66%
Interest Expense $101.0K -$42.45K -$38.19K
YoY Change 408.92% 11.16% -1343.97%
% of Operating Profit
Other Income/Expense, Net $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Pretax Income -$1.742M -$3.377M
YoY Change -48.42% 4.56%
Income Tax $0.00 $5.353K $0.00
% Of Pretax Income
Net Earnings -$2.044M -$1.747M -$3.377M
YoY Change 74.58% -48.27% 4.56%
Net Earnings / Revenue -9.14% -9.6% -20.28%
Basic Earnings Per Share
Diluted Earnings Per Share -$0.01 -$0.01 -$0.03
COMMON SHARES
Basic Shares Outstanding 140.4M shares 139.9M shares 121.6M shares
Diluted Shares Outstanding 140.5M shares 140.1M shares 127.2M shares

Balance Sheet

Concept 2024 Q3 2024 Q2 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.012M $5.045M
YoY Change -60.12% -40.07%
Cash & Equivalents $2.587M $2.012M $5.000M
Short-Term Investments $0.00
Other Short-Term Assets $1.038M $828.6K
YoY Change 25.28% -22.88%
Inventory
Prepaid Expenses $882.6K $1.038M
Receivables $8.782M $8.081M $10.80M
Other Receivables $0.00 $0.00
Total Short-Term Assets $12.25M $11.13M $16.67M
YoY Change -32.3% -33.22% -26.2%
LONG-TERM ASSETS
Property, Plant & Equipment $1.792M $1.757M $1.680M
YoY Change 6.51% 4.55% -0.48%
Goodwill $9.853M $9.853M $9.853M
YoY Change 0.0% 0.0% 0.0%
Intangibles $4.012M $4.173M $5.157M
YoY Change -18.3% -19.09% -16.03%
Long-Term Investments $0.00
YoY Change -100.0%
Other Assets $78.35K $128.3K $685.2K
YoY Change -1.5% -81.27% 1818.17%
Total Long-Term Assets $16.73M $17.33M $17.62M
YoY Change -7.45% -1.64% -11.45%
TOTAL ASSETS
Total Short-Term Assets $12.25M $11.13M $16.67M
Total Long-Term Assets $16.73M $17.33M $17.62M
Total Assets $28.98M $28.46M $34.28M
YoY Change -19.88% -16.99% -19.29%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.089M $6.076M $6.193M
YoY Change -8.73% -1.89% -0.86%
Accrued Expenses $8.317M $7.601M $8.241M
YoY Change -1.47% -7.77% 18.38%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $27.37K $74.10K
YoY Change -63.06% -29.28%
Total Short-Term Liabilities $15.68M $13.95M $14.63M
YoY Change -4.63% -4.66% 7.02%
LONG-TERM LIABILITIES
Long-Term Debt $5.970K $33.34K
YoY Change -82.09% -38.09%
Other Long-Term Liabilities $0.00 $0.00 $3.555K
YoY Change -100.0% -100.0% -76.2%
Total Long-Term Liabilities $901.2K $972.3K $154.2K
YoY Change 4.01% 530.4% -49.42%
TOTAL LIABILITIES
Total Short-Term Liabilities $15.68M $13.95M $14.63M
Total Long-Term Liabilities $901.2K $972.3K $154.2K
Total Liabilities $16.58M $14.92M $14.78M
YoY Change -4.2% 0.92% 5.78%
SHAREHOLDERS EQUITY
Retained Earnings -$173.4M -$171.3M -$163.9M
YoY Change 5.06% 4.53% 9.76%
Common Stock $140.5K $140.4K $137.8K
YoY Change 1.8% 1.9% 14.97%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $12.40M $13.54M $19.50M
YoY Change
Total Liabilities & Shareholders Equity $28.98M $28.46M $34.28M
YoY Change -19.88% -16.99% -19.29%

Cashflow Statement

Concept 2024 Q3 2024 Q2 2023 Q2
OPERATING ACTIVITIES
Net Income -$2.044M -$1.747M -$3.377M
YoY Change 74.58% -48.27% 4.56%
Depreciation, Depletion And Amortization $440.9K $430.7K $705.6K
YoY Change 4.77% -38.96% 89.19%
Cash From Operating Activities $195.4K $397.1K
YoY Change -50.79% -60.75%
INVESTING ACTIVITIES
Capital Expenditures $461.7K $425.2K
YoY Change 8.59% -195.59%
Acquisitions
YoY Change
Other Investing Activities $0.00 -$10.00
YoY Change -100.0% -100.01%
Cash From Investing Activities -$461.7K -$425.2K
YoY Change 8.59% 19.26%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -153.8K 3.104M
YoY Change -104.95% -12352.59%
NET CHANGE
Cash From Operating Activities 195.4K 397.1K
Cash From Investing Activities -461.7K -425.2K
Cash From Financing Activities -153.8K 3.104M
Net Change In Cash -420.1K 3.076M
YoY Change -113.66% 388.24%
FREE CASH FLOW
Cash From Operating Activities $195.4K $397.1K
Capital Expenditures $461.7K $425.2K
Free Cash Flow -$266.3K -$28.04K
YoY Change 849.75% -101.93%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Profit Loss
ProfitLoss
3858849 usd
us-gaap Profit Loss
ProfitLoss
6817343 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1350004 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
1317203 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
36115 usd
us-gaap Finance Lease Right Of Use Asset Amortization
FinanceLeaseRightOfUseAssetAmortization
58013 usd
us-gaap Share Based Compensation
ShareBasedCompensation
714993 usd
us-gaap Share Based Compensation
ShareBasedCompensation
935145 usd
inuvo Derecognition Of Contingencies And Grant
DerecognitionOfContingenciesAndGrant
5000 usd
inuvo Derecognition Of Contingencies And Grant
DerecognitionOfContingenciesAndGrant
0 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
3333 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
2084 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
150000 usd
us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
150000 usd
inuvo Adjustment To Expected Loss On Accounts Receivable
AdjustmentToExpectedLossOnAccountsReceivable
1354533 usd
inuvo Adjustment To Expected Loss On Accounts Receivable
AdjustmentToExpectedLossOnAccountsReceivable
-322320 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
5353 usd
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
0 usd
us-gaap Marketable Securities Gain Loss
MarketableSecuritiesGainLoss
14418 usd
inuvo Stock Warrant Expense
StockWarrantExpense
0 usd
inuvo Stock Warrant Expense
StockWarrantExpense
-8598 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-223383 usd
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2500163 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1913 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
36917 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-2126 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-324358 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3069680 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-356230 usd
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1851978 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
239139 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1160170 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2833853 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
933955 usd
us-gaap Payments To Acquire Productive Assets
PaymentsToAcquireProductiveAssets
836428 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
0 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
2288873 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-933955 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1452445 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
592868 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
0 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
592868 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000829323
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste. 300
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
500000 shares
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2024Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
137983918 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
140434327 shares
CY2021Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
202904 usd
CY2024Q1 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
487158 usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-32442
dei Entity Registrant Name
EntityRegistrantName
INUVO, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
87-0450450
dei Entity Address Address Line1
EntityAddressAddressLine1
500 President Clinton Ave.
dei Entity Address City Or Town
EntityAddressCityOrTown
Little Rock
dei Entity Address State Or Province
EntityAddressStateOrProvince
AR
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
72201
dei City Area Code
CityAreaCode
501
dei Local Phone Number
LocalPhoneNumber
205-8508
dei Security12b Title
Security12bTitle
Common stock
dei Trading Symbol
TradingSymbol
INUV
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
140432087 shares
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18209005 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
16651405 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35232782 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28498845 usd
CY2024Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2906188 usd
CY2023Q2 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2368540 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5005230 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
5559103 usd
CY2024Q2 us-gaap Gross Profit
GrossProfit
15302817 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
14282865 usd
us-gaap Gross Profit
GrossProfit
30227552 usd
us-gaap Gross Profit
GrossProfit
22939742 usd
CY2024Q2 inuvo Advertising Costs
AdvertisingCosts
12431580 usd
CY2023Q2 inuvo Advertising Costs
AdvertisingCosts
12056616 usd
inuvo Advertising Costs
AdvertisingCosts
25534224 usd
inuvo Advertising Costs
AdvertisingCosts
19144166 usd
CY2024Q2 us-gaap Salaries And Wages
SalariesAndWages
3031231 usd
CY2023Q2 us-gaap Salaries And Wages
SalariesAndWages
3253416 usd
us-gaap Salaries And Wages
SalariesAndWages
6256090 usd
us-gaap Salaries And Wages
SalariesAndWages
6676257 usd
CY2024Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1539393 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2311885 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2227903 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3893774 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
17002204 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
17621917 usd
us-gaap Operating Expenses
OperatingExpenses
34018217 usd
us-gaap Operating Expenses
OperatingExpenses
29714197 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-1699387 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3339052 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-3790665 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-6774455 usd
CY2024Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-42451 usd
CY2023Q2 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-38186 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-62831 usd
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-57306 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
14418 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5353 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5353 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1747191 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3377238 usd
us-gaap Net Income Loss
NetIncomeLoss
-3858849 usd
us-gaap Net Income Loss
NetIncomeLoss
-6817343 usd
CY2024Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
0 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
84868 usd
CY2024Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1747191 usd
CY2023Q2 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3377238 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3858849 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6732475 usd
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.05
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
140118532 shares
CY2023Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
127249916 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
139453962 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
124115098 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
140118532 shares
CY2023Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
127249916 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
139453962 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
124115098 shares
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
35665 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
64159 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
0 usd
us-gaap Proceeds From Sale Of Available For Sale Securities Debt
ProceedsFromSaleOfAvailableForSaleSecuritiesDebt
61136 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3665000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
298760 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
166872 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-334425 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3495105 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-2428550 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
2113697 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
4440454 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2931415 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2011904 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
5045112 usd
us-gaap Interest Paid Net
InterestPaidNet
96645 usd
us-gaap Interest Paid Net
InterestPaidNet
67532 usd
inuvo Acquisition Of Right Of Use Asset For Operating Lease Liability
AcquisitionOfRightOfUseAssetForOperatingLeaseLiability
335286 usd
inuvo Acquisition Of Right Of Use Asset For Operating Lease Liability
AcquisitionOfRightOfUseAssetForOperatingLeaseLiability
0 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
16982186 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2111658 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
396312 usd
CY2024Q1 inuvo Stock Issued For Vested Restricted Stock Awards Amount
StockIssuedForVestedRestrictedStockAwardsAmount
0 usd
CY2024Q1 inuvo Shares Withheld For Taxes On Vested Restricted Stock
SharesWithheldForTaxesOnVestedRestrictedStock
-161973 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
15104867 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-1747191 usd
CY2024Q2 us-gaap Share Based Compensation
ShareBasedCompensation
318681 usd
CY2024Q2 inuvo Stock Issued For Vested Restricted Stock Awards Amount
StockIssuedForVestedRestrictedStockAwardsAmount
0 usd
CY2024Q2 inuvo Shares Withheld For Taxes On Vested Restricted Stock
SharesWithheldForTaxesOnVestedRestrictedStock
-136787 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
13539570 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
21749316 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3440105 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
84868 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
432084 usd
CY2023Q1 inuvo Stock Issued For Vested Restricted Stock Awards Amount
StockIssuedForVestedRestrictedStockAwardsAmount
0 usd
CY2023Q1 inuvo Shares Withheld For Taxes On Vested Restricted Stock
SharesWithheldForTaxesOnVestedRestrictedStock
-166872 usd
CY2023Q1 inuvo Reversal Of Expense Related To A Change In Warrant Vesting
ReversalOfExpenseRelatedToAChangeInWarrantVesting
-9874 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
18649417 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3377238 usd
CY2023Q2 us-gaap Share Based Compensation
ShareBasedCompensation
503061 usd
CY2023Q2 inuvo Stock Issued For Vested Restricted Stock Awards Amount
StockIssuedForVestedRestrictedStockAwardsAmount
0 usd
CY2023Q2 us-gaap Stock And Warrants Issued During Period Value Preferred Stock And Warrants
StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants
1276 usd
CY2023Q2 inuvo Capital Raise Net Of Issuance Costs Amount
CapitalRaiseNetOfIssuanceCostsAmount
3665000 usd
CY2023Q2 inuvo Agp Closing At The Market Sale Amount
AgpClosingAtTheMarketSaleAmount
61136 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
19502652 usd
CY2024Q2 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
2000000 usd
CY2024Q2 inuvo Working Capital Net
WorkingCapitalNet
-2800000 usd
CY2024Q2 inuvo Accumulated Deficit
AccumulatedDeficit
-171300000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-size:10pt;font-family:times new roman;margin:0px">The preparation of financial statements, in accordance with GAAP, requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, net revenues and expenses and disclosure of contingent assets and liabilities. The estimates and assumptions used in the accompanying consolidated financial statements are based upon management’s regular evaluation of the relevant facts and circumstances as of the date of the consolidated financial statements. We regularly evaluate estimates and assumptions related to capitalized labor, goodwill and purchased intangible asset valuations and income tax valuation allowance. Actual results may differ from the estimates and assumptions used in preparing the accompanying consolidated financial statements, and such differences could be material.</p>
CY2024Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
18209005 usd
CY2023Q2 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
16651405 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
35232782 usd
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
28498845 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-size:10pt;font-family:times new roman;margin:0px">For the three-month period ending June 30, 2024, one Platform customer accounted for 72.9% of our overall revenue and for the six-month period ended June 30, 2024, 74.3% of our overall revenue. That same customer accounted for 53.1% of our gross accounts receivable balance as of June 30, 2024. As of December 31, 2023, the same customer accounted for 50.5% of our gross accounts receivable balance.</p>
CY2024Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18968663 usd
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
18204082 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17211674 usd
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16523294 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1756989 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1680788 usd
CY2024Q2 us-gaap Depreciation
Depreciation
430676 usd
CY2023Q2 us-gaap Depreciation
Depreciation
432053 usd
us-gaap Depreciation
Depreciation
857754 usd
us-gaap Depreciation
Depreciation
824954 usd
CY2024Q2 inuvo Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross
FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross
12355000 usd
CY2024Q2 inuvo Intangible Assets Accumulated Amortizationand Impairment Loss
IntangibleAssetsAccumulatedAmortizationandImpairmentLoss
-8182459 usd
CY2024Q2 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4172541 usd
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
492250 usd
CY2024Q2 us-gaap Goodwill Gross
GoodwillGross
9853342 usd
CY2024Q2 us-gaap Goodwill
Goodwill
9853342 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
277667 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
469500 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
469500 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
469500 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
469500 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
1626874 usd
CY2024Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3782541 usd
CY2023Q4 inuvo Finite Livedand Indefinite Lived Intangible Assets Long Term Portion Gross
FiniteLivedandIndefiniteLivedIntangibleAssetsLongTermPortionGross
17565000 usd
CY2023Q4 inuvo Intangible Assets Accumulated Amortizationand Impairment Loss
IntangibleAssetsAccumulatedAmortizationandImpairmentLoss
-12900209 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
4664791 usd
CY2023 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
984500 usd
CY2023Q4 us-gaap Goodwill Gross
GoodwillGross
9853342 usd
CY2023Q4 us-gaap Goodwill
Goodwill
9853342 usd
CY2024Q2 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
4255119 usd
CY2023Q4 us-gaap Accrued Marketing Costs Current
AccruedMarketingCostsCurrent
5717983 usd
CY2024Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1325369 usd
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1544460 usd
CY2024Q2 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2009943 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
622960 usd
CY2024Q2 inuvo Accrued Grant Current
AccruedGrantCurrent
0 usd
CY2023Q4 inuvo Accrued Grant Current
AccruedGrantCurrent
35000 usd
CY2024Q2 inuvo Accrued Taxes Current Portion
AccruedTaxesCurrentPortion
10241 usd
CY2023Q4 inuvo Accrued Taxes Current Portion
AccruedTaxesCurrentPortion
6076 usd
CY2024Q2 inuvo Accrued Liabilities And Lease Liability Current
AccruedLiabilitiesAndLeaseLiabilityCurrent
7600672 usd
CY2023Q4 inuvo Accrued Liabilities And Lease Liability Current
AccruedLiabilitiesAndLeaseLiabilityCurrent
7926479 usd
CY2021Q3 inuvo Referral Agreement
ReferralAgreement
1500000 usd
CY2021Q3 us-gaap Class Of Warrant Or Right Number Of Securities Called By Each Warrant Or Right
ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
300000 shares
CY2021Q3 inuvo Referral Agreement Term
ReferralAgreementTerm
five years
inuvo Amortization Of Referral Agreement As Marketing Expense
AmortizationOfReferralAgreementAsMarketingExpense
850000 usd
CY2021Q3 inuvo Class Of Warrant Or Right Vesting Period
ClassOfWarrantOrRightVestingPeriod
two years
CY2023Q3 inuvo Commission Offset Amount
CommissionOffsetAmount
960852 usd
CY2023Q3 us-gaap Accounts Receivable Purchase
AccountsReceivablePurchase
642202 usd
CY2023 inuvo Reduction In Commission Expense
ReductionInCommissionExpense
67000 usd
CY2023 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
52000 usd
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
17000 usd
CY2024Q2 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
5000 usd
CY2024Q2 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
42619514 usd
CY2024Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
41543303 usd
CY2024Q2 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
1170800 usd
CY2024Q2 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
94589 usd
CY2023Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
89238 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
24550000 shares
us-gaap Share Based Compensation
ShareBasedCompensation
714993 usd
us-gaap Share Based Compensation
ShareBasedCompensation
935145 usd
CY2024Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
2180386 usd
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
0 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
6960020 shares
CY2024Q2 inuvo Sharebased Compensation Arrangementby Sharebased Payment Award Numberof Shares Exercised
SharebasedCompensationArrangementbySharebasedPaymentAwardNumberofSharesExercised
9930783 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant
7659197 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
24550000 shares
inuvo Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Forfeiture Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedForfeitureRate
0 pure
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
7010016 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.48
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
3330000 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.41
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
3296662 shares
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue
0.64
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
83334 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
0.52
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
6960020 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.37
CY2021Q3 inuvo Referral Agreement Term
ReferralAgreementTerm
five years
CY2021Q3 inuvo Class Of Warrant Or Right Granted In Period
ClassOfWarrantOrRightGrantedInPeriod
300000 shares
CY2021Q3 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.72
CY2021Q3 inuvo Class Of Warrant Or Right Number Of Tranches
ClassOfWarrantOrRightNumberOfTranches
two tranches
CY2021Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
149551 usd
CY2021Q3 inuvo Class Of Warrant Or Right Term
ClassOfWarrantOrRightTerm
seven-year
CY2022Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
85862 shares
CY2023Q3 inuvo Shares Vested
SharesVested
21136 shares
CY2023 inuvo Shares Vested Reversed Due Hange In The Probability Of Performance Criteria
SharesVestedReversedDueHangeInTheProbabilityOfPerformanceCriteria
7900 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
193000 shares
inuvo Shares Vested
SharesVested
107000 shares
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1029164 usd
CY2024Q2 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
36449 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
805786 usd
CY2023Q4 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
72560 usd
inuvo Finance And Operating Lease Right Of Use Asset Amortization
FinanceAndOperatingLeaseRightOfUseAssetAmortization
36115 usd
inuvo Finance And Operating Lease Right Of Use Asset Amortization
FinanceAndOperatingLeaseRightOfUseAssetAmortization
58013 usd
CY2023Q3 inuvo Lessee Operating Lease Area Of Office Space
LesseeOperatingLeaseAreaOfOfficeSpace
4128 sqft
CY2023Q3 inuvo Lessee Operating Leases Term Of Contract
LesseeOperatingLeasesTermOfContract
sixty-five months
CY2023Q3 inuvo Lessee Operating Lease Abatement Period
LesseeOperatingLeaseAbatementPeriod
five months
CY2023Q3 inuvo Lessee Operating Lease Lease Not Yet Commenced Lease Cost Year One
LesseeOperatingLeaseLeaseNotYetCommencedLeaseCostYearOne
208000 usd
CY2023Q3 inuvo Lessee Operating Lease Annual Increase In Lease Cost Percentage
LesseeOperatingLeaseAnnualIncreaseInLeaseCostPercentage
0.03 pure
CY2024Q1 inuvo Lessee Operating Leases Term Of Contract
LesseeOperatingLeasesTermOfContract
thirty-six months
us-gaap Lease Expiration Date1
LeaseExpirationDate1
2027-01-31
CY2024Q1 inuvo Lessee Operating Lease Lease Not Yet Commenced Lease Cost Year One
LesseeOperatingLeaseLeaseNotYetCommencedLeaseCostYearOne
127000 usd
CY2024Q1 inuvo Lessee Operating Lease Annual Increase In Lease Cost Percentage
LesseeOperatingLeaseAnnualIncreaseInLeaseCostPercentage
0.02 pure
CY2024Q2 us-gaap Operating Lease Payments
OperatingLeasePayments
91908 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
148272 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
170479 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
349194 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
354565 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
237867 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
233727 usd
CY2024Q2 inuvo Lessee Operating Lease Liability To Be Paid After Year Four
LesseeOperatingLeaseLiabilityToBePaidAfterYearFour
19525 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1365357 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
251323 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1114034 usd
inuvo Weighted Average Remaining Lease Term
WeightedAverageRemainingLeaseTerm
P3Y2M12D
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.105 pure
CY2024Q2 inuvo Finance Lease Payments
FinanceLeasePayments
18321 usd
inuvo Finance Lease Payments
FinanceLeasePayments
35671 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Remainder Of Fiscal Year
FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear
15618 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due Next Twelve Months
FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
18491 usd
CY2024Q2 us-gaap Finance Lease Liability Payments Due
FinanceLeaseLiabilityPaymentsDue
34109 usd
CY2024Q2 us-gaap Finance Lease Liability Undiscounted Excess Amount
FinanceLeaseLiabilityUndiscountedExcessAmount
765 usd
CY2024Q2 us-gaap Finance Lease Liability
FinanceLeaseLiability
33344 usd
inuvo Weighted Average Remaining Lease Terms
WeightedAverageRemainingLeaseTerms
P1Y2M12D
CY2024Q2 us-gaap Finance Lease Weighted Average Discount Rate Percent
FinanceLeaseWeightedAverageDiscountRatePercent
0.0625 pure
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1645045 usd
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1440678 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-1354533 usd
CY2023 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
786549 usd
us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
62587 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Write Offs
AllowanceForDoubtfulAccountsReceivableWriteOffs
582189 usd
us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
4700 usd
CY2023 us-gaap Allowance For Doubtful Accounts Receivable Recoveries
AllowanceForDoubtfulAccountsReceivableRecoveries
7 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
232625 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
1645045 usd
CY2024Q2 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
232625 usd
CY2023 inuvo Increase Decrease In Allowance For Doubtful Accounts Receivable
IncreaseDecreaseInAllowanceForDoubtfulAccountsReceivable
1412420 usd

Files In Submission

Name View Source Status
0001654954-24-010179-index-headers.html Edgar Link pending
0001654954-24-010179-index.html Edgar Link pending
0001654954-24-010179.txt Edgar Link pending
0001654954-24-010179-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
inuvo-20240630.xsd Edgar Link pending
inuvo_10q.htm Edgar Link pending
inuvo_10qimg2.jpg Edgar Link pending
inuvo_ex311.htm Edgar Link pending
inuvo_ex312.htm Edgar Link pending
inuvo_ex321.htm Edgar Link pending
inuvo_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
inuvo-20240630_pre.xml Edgar Link unprocessable
inuvo-20240630_lab.xml Edgar Link unprocessable
inuvo_10q_htm.xml Edgar Link completed
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
inuvo-20240630_def.xml Edgar Link unprocessable
inuvo-20240630_cal.xml Edgar Link unprocessable